{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:18:29Z","timestamp":1764656309970,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10072-024-07897-8","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:33:14Z","timestamp":1732851194000},"page":"861-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of peripapillary retinal nerve fiber layer atrophy with cognitive impairment in patients with neuromyelitis optica spectrum disorder"],"prefix":"10.1007","volume":"46","author":[{"given":"Mahdi","family":"Barzegar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4881-958X","authenticated-orcid":false,"given":"Fereshteh","family":"Ashtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahele","family":"Kafieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshia","family":"Ghalamkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Afshari-Safavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"1","key":"7897_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B (2020) Neuromyelitis optica. Nat Reviews Disease Primers 6(1):85","journal-title":"Nat Reviews Disease Primers"},{"issue":"9","key":"7897_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Pr\u00f6bstel A-K, Aktas O, Alexopoulos H, Amato M-P, Asgari N, Banwell B, Bennett J (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20(9):762\u2013772","journal-title":"Lancet Neurol"},{"issue":"11","key":"7897_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84(11):1165\u20131173","journal-title":"Neurology"},{"issue":"10","key":"7897_CR4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/14737175.2021.1982697","volume":"21","author":"T-Y Lin","year":"2021","unstructured":"Lin T-Y, Chien C, Lu A, Paul F, Zimmermann HG (2021) Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review. Expert Rev Neurother 21(10):1101\u20131123","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"7897_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/jnnp-2021-326386","volume":"93","author":"H Masuda","year":"2022","unstructured":"Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Muto M, Ohtani R, Aoki R, Kuwabara S (2022) Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry 93(1):32\u201340","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7897_CR6","doi-asserted-by":"crossref","unstructured":"Finke C, Heine J, Pache F, Lacheta A, Borisow N, Kuchling J, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F (2016) Normal volumes and microstructural integrity of deep gray matter structures in AQP4\u2009+\u2009NMOSD. Neurology-Neuroimmunology Neuroinflammation 3(3)","DOI":"10.1212\/NXI.0000000000000229"},{"issue":"9","key":"7897_CR7","doi-asserted-by":"publisher","first-page":"e0137715","DOI":"10.1371\/journal.pone.0137715","volume":"10","author":"L Matthews","year":"2015","unstructured":"Matthews L, Kolind S, Brazier A, Leite MI, Brooks J, Traboulsee A, Jenkinson M, Johansen-Berg H, Palace J (2015) Imaging surrogates of disease activity in neuromyelitis optica allow distinction from multiple sclerosis. PLoS ONE 10(9):e0137715","journal-title":"PLoS ONE"},{"issue":"17","key":"7897_CR8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1212\/WNL.0000000000002067","volume":"85","author":"Y Liu","year":"2015","unstructured":"Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, Shen Y, Yan Y, Yang L, Wang Q (2015) Structural MRI substrates of cognitive impairment in neuromyelitis optica. Neurology 85(17):1491\u20131499","journal-title":"Neurology"},{"issue":"2","key":"7897_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ene.13224","volume":"24","author":"JW Hyun","year":"2017","unstructured":"Hyun JW, Park G, Kwak K, Jo HJ, Joung A, Kim JH, Lee S, Kim S, Lee JM, Kim SH (2017) Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis. Eur J Neurol 24(2):437\u2013445","journal-title":"Eur J Neurol"},{"issue":"1","key":"7897_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/archneurol.2007.16","volume":"65","author":"F Blanc","year":"2008","unstructured":"Blanc F, Z\u00e9phir H, Lebrun C, Labauge P, Castelnovo G, Fleury M, Sellal F, Tranchant C, Dujardin K, Vermersch P (2008) Cognitive functions in neuromyelitis optica. Arch Neurol 65(1):84\u201388","journal-title":"Arch Neurol"},{"key":"7897_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fneur.2019.00608","volume":"10","author":"FC Oertel","year":"2019","unstructured":"Oertel FC, Schlie\u00dfeit J, Brandt AU, Paul F (2019) Cognitive impairment in neuromyelitis optica spectrum disorders: a review of clinical and neuroradiological features. Front Neurol 10:608","journal-title":"Front Neurol"},{"key":"7897_CR12","doi-asserted-by":"crossref","unstructured":"H\u00fcmmert MW, Stern C, Paul F, Duchow A, Bellmann-Strobl J, Ayzenberg I, Schwake C, Kleiter I, Hellwig K, Jarius S (2023) Cognition in patients with neuromyelitis optica spectrum disorders: a prospective multicentre study of 217 patients (CogniNMO-Study). Multiple Scler J 29(7):819\u201331","DOI":"10.1177\/13524585231151212"},{"issue":"14","key":"7897_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1177\/1352458515576982","volume":"21","author":"N Zhang","year":"2015","unstructured":"Zhang N, Li Y, Fu Y, Shao J, Luo L, Yang L, Shi F, Liu Y (2015) Cognitive impairment in Chinese neuromyelitis optica. Multiple Scler J 21(14):1839\u20131846","journal-title":"Multiple Scler J"},{"key":"7897_CR14","doi-asserted-by":"publisher","first-page":"104492","DOI":"10.1016\/j.msard.2022.104492","volume":"70","author":"F Ashtari","year":"2023","unstructured":"Ashtari F, Manouchehri N, Shaygannejad V, Barekatain M, Adibi I, Afshari-Safavi A, Ramezani N, Ghalamkari A, Barzegar M (2023) Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis. Multiple Scler Relat Disorders 70:104492","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"7897_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ana.23721","volume":"73","author":"E Saji","year":"2013","unstructured":"Saji E, Arakawa M, Yanagawa K, Toyoshima Y, Yokoseki A, Okamoto K, Otsuki M, Akazawa K, Kakita A, Takahashi H (2013) Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 73(1):65\u201376","journal-title":"Ann Neurol"},{"issue":"10","key":"7897_CR16","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3174\/ajnr.A4403","volume":"36","author":"Q Wang","year":"2015","unstructured":"Wang Q, Zhang N, Qin W, Li Y, Fu Y, Li T, Shao J, Yang L, Shi F-D, Yu C (2015) Gray matter volume reduction is associated with cognitive impairment in neuromyelitis optica. Am J Neuroradiol 36(10):1822\u20131829","journal-title":"Am J Neuroradiol"},{"issue":"4","key":"7897_CR17","doi-asserted-by":"publisher","first-page":"e33878","DOI":"10.1371\/journal.pone.0033878","volume":"7","author":"F Blanc","year":"2012","unstructured":"Blanc F, Noblet V, Jung B, Rousseau F, Renard F, Bourre B, Longato N, Cremel N, Di Bitonto L, Kleitz C (2012) White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS ONE 7(4):e33878","journal-title":"PLoS ONE"},{"issue":"12","key":"7897_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ncpneuro0950","volume":"4","author":"EM Frohman","year":"2008","unstructured":"Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664\u2013675","journal-title":"Nat Clin Pract Neurol"},{"key":"7897_CR19","unstructured":"Oertel FC, Specovius S, Zimmermann HG, Chien C, Motamedi S, Bereuter C, Cook L, Peixoto MAL, Fontanelle MA, Kim HJ (2021) Retinal optical coherence tomography in neuromyelitis optica. Neurology-Neuroimmunology Neuroinflammation 8(6)"},{"key":"7897_CR20","doi-asserted-by":"publisher","first-page":"102625","DOI":"10.1016\/j.msard.2020.102625","volume":"47","author":"F Ashtari","year":"2021","unstructured":"Ashtari F, Ataei A, Kafieh R, Khodabandeh Z, Barzegar M, Raei M, Dehghani A, Mansurian M (2021) Optical coherence tomography in Neuromyelitis Optica spectrum disorder and multiple sclerosis: a population-based study. Multiple Scler Relat Disorders 47:102625","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"7897_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-017-0123-5","volume":"9","author":"FC Oertel","year":"2018","unstructured":"Oertel FC, Zimmermann H, Paul F, Brandt AU (2018) Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy. Epma J 9(1):21\u201333","journal-title":"Epma J"},{"issue":"5","key":"7897_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","volume":"32","author":"J Britze","year":"2018","unstructured":"Britze J, Frederiksen JL (2018) Optical coherence tomography in multiple sclerosis. Eye 32(5):884\u2013888","journal-title":"Eye"},{"issue":"9","key":"7897_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/1352458513519838","volume":"20","author":"F von Glehn","year":"2014","unstructured":"von Glehn F, Jarius S, Cavalcanti Lira RP, Alves Ferreira MC, von Glehn FHR, Costa e Castro SM, Beltramini GC, Bergo FP, Farias AS, Brand\u00e3o CO (2014) Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Multiple Scler J 20(9):1189\u20131197","journal-title":"Multiple Scler J"},{"key":"7897_CR24","doi-asserted-by":"crossref","unstructured":"Mirmosayyeb O, Zivadinov R, Weinstock-Guttman B, Benedict RH, Jakimovski D (2022) Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis. J Neurol 270(3):1266\u201385","DOI":"10.1007\/s00415-022-11449-5"},{"issue":"13","key":"7897_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1177\/13524585231198760","volume":"29","author":"N Cerd\u00e1-Fuertes","year":"2023","unstructured":"Cerd\u00e1-Fuertes N, Stoessel M, Mickeliunas G, Pless S, Cagol A, Barakovic M, Maceski AM, \u00c1lvarez Gonz\u00e1lez C, D\u2019Souza M, Schaedlin S (2023) Optical coherence tomography versus other biomarkers: associations with physical and cognitive disability in multiple sclerosis. Multiple Scler J 29(13):1540\u20131550","journal-title":"Multiple Scler J"},{"issue":"2","key":"7897_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, De Seze J, Fujihara K, Greenberg B, Jacob A (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"key":"7897_CR27","doi-asserted-by":"publisher","first-page":"104852","DOI":"10.1016\/j.msard.2023.104852","volume":"77","author":"F Ashtari","year":"2023","unstructured":"Ashtari F, Mehdipour R, Eini A, Ghalamkari A (2023) Epidemiologic and clinical characteristics of neuromyelitis optica spectrum disorder patients, a seven years follow-up study from Iran. Multiple Scler Relat Disorders 77:104852","journal-title":"Multiple Scler Relat Disorders"},{"issue":"3","key":"7897_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 22(3):268\u2013282","journal-title":"Lancet Neurol"},{"issue":"11","key":"7897_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131444","journal-title":"Neurology"},{"issue":"6","key":"7897_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/13854046.2012.694912","volume":"26","author":"A Eshaghi","year":"2012","unstructured":"Eshaghi A, Riyahi-Alam S, Roostaei T, Haeri G, Aghsaei A, Aidi MR, Pouretemad HR, Zarei M, Farhang S, Saeedi R (2012) Validity and reliability of a Persian translation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Clin Neuropsychol 26(6):975\u2013984","journal-title":"Clin Neuropsychol"},{"issue":"2","key":"7897_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S, Balk L, Costello F, Albrecht P, Balcer L, Calabresi P, Frederiksen J, Frohman E, Green A, Klistorner A (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Multiple Scler J 21(2):163\u2013170","journal-title":"Multiple Scler J"},{"issue":"2","key":"7897_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","volume":"97","author":"A Aytulun","year":"2021","unstructured":"Aytulun A, Cruz-Herranz A, Aktas O, Balcer LJ, Balk L, Barboni P, Blanco AA, Calabresi PA, Costello F, Sanchez-Dalmau B (2021) APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology 97(2):68\u201379","journal-title":"Neurology"},{"issue":"6","key":"7897_CR33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","volume":"15","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574\u2013584","journal-title":"Lancet Neurol"},{"key":"7897_CR34","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.msard.2021.102757","volume":"49","author":"AN Moghadasi","year":"2021","unstructured":"Moghadasi AN, Mirmosayyeb O, Mohammadi A, Sahraian MA, Ghajarzadeh M (2021) The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis. Multiple Scler Relat Disorders 49:102757","journal-title":"Multiple Scler Relat Disorders"},{"key":"7897_CR35","doi-asserted-by":"publisher","first-page":"958441","DOI":"10.3389\/fneur.2022.958441","volume":"13","author":"L Kong","year":"2022","unstructured":"Kong L, Lang Y, Wang X, Wang J, Chen H, Shi Z, Zhou H (2022) Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder. Front Neurol 13:958441","journal-title":"Front Neurol"},{"issue":"1","key":"7897_CR36","doi-asserted-by":"publisher","first-page":"e207965","DOI":"10.1212\/WNL.0000000000207965","volume":"102","author":"L Vlahovic","year":"2024","unstructured":"Vlahovic L, McDonald J, Hinman J, Tomczak A, Lock C, Palmer CA, Cook LJ, Yeaman MR, Burnett MK, Deutsch GK (2024) Prevalence, demographic, and clinical factors associated with cognitive dysfunction in patients with neuromyelitis optica spectrum disorder. Neurology 102(1):e207965","journal-title":"Neurology"},{"issue":"2","key":"7897_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1352458517740216","volume":"25","author":"G Bsteh","year":"2019","unstructured":"Bsteh G, Hegen H, Teuchner B, Amprosi M, Berek K, Ladst\u00e4tter F, Wurth S, Auer M, Di Pauli F, Deisenhammer F (2019) Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Multiple Scler J 25(2):196\u2013203","journal-title":"Multiple Scler J"},{"key":"7897_CR38","doi-asserted-by":"crossref","unstructured":"Alba-Arbalat S, Solana E, Lopez-Soley E, Camos-Carreras A, Martinez-Heras E, Viv\u00f3 F, Pulido-Valdeolivas I, Andorra M, Sepulveda M, Cabrera JM (2023) Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry","DOI":"10.1136\/jnnp-2023-332332"},{"issue":"2","key":"7897_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1352458517694090","volume":"24","author":"D Coric","year":"2018","unstructured":"Coric D, Balk LJ, Verrijp M, Eijlers A, Schoonheim MM, Killestein J, Uitdehaag BM, Petzold A (2018) Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Multiple Scler J 24(2):158\u2013166","journal-title":"Multiple Scler J"},{"issue":"1","key":"7897_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-13-167","volume":"13","author":"L Wieder","year":"2013","unstructured":"Wieder L, G\u00e4de G, Pech LM, Zimmermann H, Wernecke K-D, D\u00f6rr J-M, Bellmann-Strobl J, Paul F, Brandt AU (2013) Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study. BMC Neurol 13(1):1\u20138","journal-title":"BMC Neurol"},{"issue":"6","key":"7897_CR41","doi-asserted-by":"publisher","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151","volume":"8","author":"E Schneider","year":"2013","unstructured":"Schneider E, Zimmermann H, Oberwahrenbrock T, Kaufhold F, Kadas EM, Petzold A, Bilger F, Borisow N, Jarius S, Wildemann B (2013) Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS ONE 8(6):e66151","journal-title":"PLoS ONE"},{"issue":"2","key":"7897_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ophtha.2012.07.066","volume":"120","author":"DB Fernandes","year":"2013","unstructured":"Fernandes DB, Raza AS, Nogueira RG, Wang D, Callegaro D, Hood DC, Monteiro ML (2013) Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology 120(2):387\u2013394","journal-title":"Ophthalmology"},{"issue":"12","key":"7897_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/jnnp-2018-318382","volume":"89","author":"FC Oertel","year":"2018","unstructured":"Oertel FC, Havla J, Roca-Fern\u00e1ndez A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P (2018) Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry 89(12):1259\u20131265","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7897_CR44","doi-asserted-by":"crossref","unstructured":"Baetge SJ, Dietrich M, Filser M, Renner A, Stute N, Gasis M, Weise M, Lepka K, Graf J, Goebels N (2021) Association of retinal layer thickness with cognition in patients with multiple sclerosis. Neurology-Neuroimmunology Neuroinflammation 8(4)","DOI":"10.1212\/NXI.0000000000001018"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07897-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07897-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07897-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:16:40Z","timestamp":1737969400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07897-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7897"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07897-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The regional bioethics committee of Isfahan University of Medical Sciences approved the study (ethical code: IR.ARI.MUI.REC.1401.289), which was in accordance with the principles of the Declaration of Helsinki and its later amendments. All participants were informed about the objectives of the study and signed the written informed consents before enrollment to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Authors report no conflict of interest relevant to the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}